Anxiety Disorders
📧 Sign up to get email alerts when something new happens for Anxiety Disorders.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2021-02-05FDA Approved: ATIVAN — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for ATIVAN (lorazepam) submitted by Bausch Health US LLC, resulting in a labeling change for the…
-
FDA approval · 2021-02-05FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for chlordiazepoxide hydrochloride by Epic Pharma LLC, indicating a regulatory modification to an ap…
-
FDA approval · 2021-02-05FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Diazepam, approving a generic version of the drug.
-
CLINICAL_TRIALS research · 2021-01-27Clinical Trial Update: Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong [Phase 2, Phase 3]
Clinical trial update on a unified protocol for treating common mental disorders in adolescents in Hong Kong, completed phases 2 and 3.
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: Tenoten® in the Treatment of Somatoform, Stress-related and Other Neurotic Disorders [Phase 4]
Phase 4 clinical trial update for Tenoten in anxiety disorders; results posted after completion.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Study of Treatment for Opioid Dependence and Anxiety Disorders [NA]
A completed clinical trial update on a treatment for opioid dependence and anxiety disorders with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress [Phase 2]
Phase 2 clinical trial update evaluating oxytocin for suppressing substance use disorders associated with chronic stress; results posted aft…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Anxiety and Depression in Epilepsy: A Treatment Study [Phase 4]
Phase 4 clinical trial examining treatment for anxiety and depression in patients with epilepsy has completed with posted results.
-
FDA approval · 2020-10-02FDA Approved: LORAZEPAM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Lorazepam from Amneal Pharmaceuticals LLC. The approval updates labeling/indication for the Lora…
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Mobile Phone Based Intervention to Protect Mental Health in Healthcare Workers at Frontline Against COVID19 [Phase 3]
Phase 3 trial evaluating a mobile phone-based intervention to protect mental health in frontline healthcare workers during COVID-19, complet…
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Mindfulness-Based Cognitive Therapy for Depression and Anxiety [Phase 4]
Phase 4 trial evaluating mindfulness-based cognitive therapy for symptoms of depression and anxiety has completed.
-
FDA approval · 2020-08-17FDA Approved: DIAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for diazepam from Hikma Pharmaceuticals USA Inc., updating the approved product under the existi…
-
CLINICAL_TRIALS trial_result · 2020-08-11Clinical Trial Update: Presurgery Anxiolysis in Children Treated With Hydroxyzine Versus Non-pharmacological Intervention (Distractoria Technique Clown) [Phase 4]
Phase 4 trial update comparing presurgery anxiolysis with hydroxyzine versus a non-pharmacological distraction technique in anxious children…
-
FDA approval · 2020-07-29FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Misemer Pharmaceuticals, Inc)
FDA approved an original ANDA for chlordiazepoxide hydrochloride and clidinium bromide, a generic combination product used for GI spasms and…
-
FDA approval · 2020-07-24FDA Approved: DOXEPIN — Original Application (Strides Pharma Science Limited)
FDA approved an original application for doxepin hydrochloride (generic doxepin) by Strides Pharma Science Limited, expanding the availabili…
-
CLINICAL_TRIALS trial_result · 2020-07-10Clinical Trial Update: Mindfulness-Based Recovery in Veterans [NA]
Clinical trial update for Mindfulness-Based Recovery in Veterans with substance abuse and depression; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Anxiety and Recurrent Abdominal Pain in Children [Phase 2, Phase 3]
Phase 2/3 clinical trial update on anxiety and recurrent abdominal pain in children; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes [NA]
A completed clinical trial examining a positive valence system enhancement treatment for anxiety and depression with reported clinical effic…
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment [Phase 4]
Phase 4 clinical trial investigating quantitative methods to guide rational treatment for anxiety in Parkinson disease; study terminated wit…
-
FDA approval · 2020-03-17FDA Approved: OXAZEPAM — Supplemental Application (TruPharma, LLC)
FDA approved a supplemental application for Oxazepam from TruPharma, LLC.
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Treating Emotional Disorders in Primary Care With Psychological Techniques [Phase 4]
Phase 4 clinical trial update evaluating psychological techniques for treating emotional disorders in primary care; completed.
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: Effects of Maternal Interpretation Biases on Child Anxiety and Related Responses [NA]
Clinical trial assessing how maternal interpretation biases influence child anxiety and related responses; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders (AIM-PC) [NA]
Clinical trial update on a low-intensity primary care intervention for anxiety disorders (AIM-PC) completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-01-27Clinical Trial Update: Relaxation Treatment for Anxiety in Adults Aged 60 or Older [NA]
A completed clinical trial evaluating relaxation treatment for anxiety in adults aged 60 or older; results posted in 2020.
-
FDA approval · 2019-12-26FDA Approved: DIAZEPAM — Original Application (Natco Pharma USA LLC)
FDA approved Natco Pharma USA LLC's original application for a generic diazepam product, enabling its marketing in the United States.